A clinical case of postinfaction aneurysm development, in a patient after COVID-19

Author:

Petrova Olga V.,Tverdokhlebova Diana K.,Shabanova Galiya R.,Nikulina Dina M.,Shashin Sergey A.

Abstract

There is no data in the literature on the course of myocardial infarction in patients after COVID-19. Purpose to use a clinical example to present a case of postinfarction left ventricular aneurysm in a patient after undergoing COVID-19. Materials and methods: Patient T., 49 years old, was admitted to the federal state budgetary institution Federal Center of Cardiovascular Surgery of the Ministry of Health of the Russian Federation (Astrakhan) with complaints of pain in the heart with irradiation in the left shoulder and lower jaw. Considers himself ill for 7 days. It is known from anamnesis of life that the patient suffered COVID-19 two weeks ago. He has been suffering from arterial hypertension for a year. Results: A clinical example demonstrates that COVID-19 affects course of myocardial infarction: it is a risk factor for the development of post infarction aneurysm of the left ventricle in the early stages after a myocardial infarction. Myocardial infarction was accompanied by the formation of pathological Q waves, impaired conduction of the right leg of the Gis bundle a decrease in the ejection fraction of the left ventricle, acute occlusion of the right coronary artery. Postinfarction aneurysm of the left ventricle had an anterior-septal apical localization. In addition, the study of highly sensitive troponin T and N-terminal fragment of the pro-brain natriuretic peptide type B in patients with myocardial infarction complicated by postinfarction aneurysm of the left ventricle after COVID-19 is also important for determining the stages of development of pathological processes in this pathology, evaluating the effectiveness of therapy and the outcome of this pathology.

Publisher

Volgograd State Medical University

Subject

Anesthesiology and Pain Medicine

Reference22 articles.

1. Mishagin V. V., Bublikov I. A., Lukianov N. G. Surgical treatment of various age groups with hemodynamically significant postinfarction left ventricular aneurism. Izvestija rossijskoj voenno-medicinskoj akademii = Russian Military Medical Academy Reports. 2018:37(1S1-2):19–25. (In Russ.).

2. Boytsov S. A. Influenza, novel coronavirus infection and cardiovascular disease. Kardiologicheskij Vestnik = Russian Cardiology Bulletin. 2021;16(1):5–10. (In Russ.).

3. Romanov Yu. A. SARS-CoV-2, COVID-19 SARS-CoV-2, Covid-19 and cardiovascular complications from the position of vascular endothelium. Kardiologicheskij Vestnik = Russian Cardiology Bulletin. 2022;17(1):21–28. (In Russ.).

4. Sabirov I., Murkamilov I., Fomin V. Clinical and pathogenetic aspects of damage to the cardiovascular system in a new coronavirus infection (COVID-19). The scientific heritage. 2020;53:10–20. (In Russ.).

5. Inciardi R.M., Lupi L., Zaccone G. et al. Cardiac Involvement in a Patient with Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020;5(7):819–824. doi:10.1001./jamacardio.2020.1096.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3